Epilepsy, a misunderstood neurological disorder, affects millions worldwide, but with proper treatment, individuals can lead ...

Financially stable with $469.5 million in cash, Praxis Precision Medicines can fund operations until 2028. Read why my rating on PRAX stock remains as a "Hold".

Acadia Pharmaceuticals Inc. and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study (EUCT: ...

Seizures and dreams are linked among patients with epilepsy, as DRF was associated with seizure frequency and localization.

Rare Epilepsy Network provides data & resources on rare epilepsies. There are hundreds of members & partners here to support ...

Symptoms can be vague or absent. This means that people may not be aware of subclinical seizures until a doctor confirms them using diagnostic tools like EEGs. Subclinical seizures may also occur ...

Cassava's strong liquidity with $128.6 million in cash supports early-stage development, yet long-term funding needs may lead ...

AI model MELD Graph improves epilepsy lesion detection, outperforming current methods—enhancing diagnosis and treatment ...

Joel Becker; President, Chief Executive Officer, Director; Neuropace Inc. Rebecca Kuhn; Chief Financial Officer ...

About 1 in 5 people with epilepsy have seizures caused by lesions in the brain, which are called focal cortical dysplasias (FCDs), researchers said in background notes. To develop the new AI, ...

Fourth Quarter 2024 Financial Results Total revenue in the fourth quarter of 2024 grew 19% to $21.5 million, compared with $18.0 million in the fourth quarter of 2023. The Company’s revenue growth was ...